Deflazacort
Back to searchMolecule Structure
Scientific Name
Deflazacort
Description of the Drug
Deflazacort is a corticosteroid used to treat Duchenne muscular dystrophy.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11921
http://www.drugbank.ca/drugs/DB11921
Brand Name(s)
Calcort, Emflaza, Zamene
Company Owner(s)
Ptc Therapeutics Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Glucocorticoid receptor | SINGLE PROTEIN | AGONIST | CHEMBL2034 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL4018 | |
DrugBank | DB11921 | |
PubChem: Thomson Pharma | 14832822 | 15955058 |
PubChem | 189821 | |
Nikkaji | J83.648F | |
EPA CompTox Dashboard | DTXSID9020378 | |
DrugCentral | 793 | |
ChemicalBook | CB8705963 | |
Guide to Pharmacology | 9477 | |
rxnorm | DEFLAZACORT | EMFLAZA |
PubChem: Drugs of the Future | 12012679 | |
ChEBI | 135720 | |
ZINC | ZINC000004212809 |